+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

From
Pain Management Drugs Market Forecast to 2033 - Product Thumbnail Image

Pain Management Drugs Market Forecast to 2033

  • Report
  • October 2025
  • 150 Pages
  • Global
From
Pregabalin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pregabalin Market - Global Forecast 2026-2032

  • Report
  • July 2026
  • 185 Pages
  • Global
From
From
From
From
From
From
From
Buprenorphine Patches Market - Global Forecast 2026-2032 - Product Thumbnail Image

Buprenorphine Patches Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
From
Cancer Pain Management Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Pain Management Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Gabapentin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Gabapentin Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
Non-Opioid Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Non-Opioid Therapeutics Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 197 Pages
  • Global
From
From
Painkillers For Dogs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Painkillers For Dogs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 181 Pages
  • Global
From
Pain Management for Pets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Pain Management for Pets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more